The extraction vs. expansion debate is dead. Here's what replaced it.

Hey there!

Right now, orthodontics is split.

On one side, clinicians are saying extractions are outdated and that jaw redevelopment and airway-focused protocols represent the future. On the other, practitioners argue that extractions remain a legitimate, evidence-based tool for specific cases.

Both sides cite research. Both sides claim the evidence supports them. And both sides have a point.

But here's the thing: the real skill isn't picking a camp. It's knowing which patient needs which tool. The meta-analyses don't support either camp. But they do support something most clinicians are missing.

So today, I'm going to walk you through what the highest-level evidence actually says—systematic reviews, CBCT-based meta-analyses, not social media hot takes. Then I want to know: which cases have changed your mind, and why?

Let's walk through both.

The case for non-extraction, expansion-based treatment.

The argument is straightforward: extractions are a 20th-century solution. Modern tools like MARPE (miniscrew-assisted rapid palatal expansion), skeletal expanders, and airway-focused protocols can address the root causes—underdeveloped jaws, restricted tongue space, breathing dysfunction.

The research backs this up. MARPE reliably opens the midpalatal suture in nongrowing patients and achieves greater skeletal expansion than traditional tooth-borne RPE. Studies show MARPE increases nasal cavity width, nasopharyngeal volume, and reduces nasal resistance. For patients with transverse deficiency and airway-related symptoms, this works.

There's also a functional component. Orofacial myofunctional disorders, mouth breathing, and low tongue posture correlate with narrower arches and increased relapse risk. Addressing these issues through myofunctional therapy, breathing retraining, and interdisciplinary care improves outcomes.

Where the evidence is strong: MARPE for transverse deficiency and selected airway concerns. Where it's thinner: applying expansion protocols universally to every crowded case. Most MARPE studies are small, retrospective, and lack long-term follow-up. Current evidence supports MARPE for specific indications, not as a replacement for extractions across the board.

The case for extraction as a legitimate tool.

Extraction remains indicated for specific malocclusions. It's not obsolete—it's selective.

A 2023 meta-analysis in the Angle Orthodontist compared extraction vs. non-extraction treatment across multiple measures. Extraction produced smaller arch widths and greater lip retraction. Non-extraction had slightly wider inter-canine width and shorter treatment time. When it came to final occlusal quality, smile esthetics, and stability metrics, the differences were minimal.

Both approaches work. The choice depends on diagnosis.

Severe bimaxillary protrusion, selected Class II and Class III camouflage, and pronounced tooth-size/arch-length discrepancies are still best managed with extraction. Forcing non-extraction treatment on these cases can compromise esthetics, create unstable outcomes, or extend treatment unnecessarily.

On the airway question: patients often worry that extractions will "ruin their face" or "block their airway." The meta-analytic data tells a different story. A 2023 systematic review using CBCT data found that premolar extraction does not increase airway collapse risk and has minimal, clinically trivial effect on upper airway volume. A 2025 meta-analysis confirmed this. When extraction is correctly planned, esthetic outcomes are comparable to non-extraction treatment, and airway harm is not a systematic risk.

Regarding TMD: systematic reviews show orthodontic treatment—extraction or non-extraction—has a weak and inconsistent association with TMD onset. Genetics, parafunction, stress, and joint morphology are far better predictors. Extractions are not a major TMD risk factor when executed properly.

Where both sides agree and where they diverge.

Both camps agree on several points: long-term retention is challenging regardless of approach; functional factors matter for stability; and individualized treatment planning beats ideology.

Where they diverge is on philosophy. The non-extraction camp sees expansion and functional treatment as a genuine shift. The extraction camp sees it as an evolution of tools, not a replacement.

What the evidence actually leaves unanswered.

Most MARPE studies are small, retrospective, and lack long-term follow-up. While extraction doesn't harm the airway on average, individual cases may vary. And while TMD is multifactorial, the role of specific orthodontic mechanics in individual patients remains incompletely understood.

What we really need: long-term prospective data on stability after adult expansion, and long-term airway and TMD outcomes across different treatment strategies. Until then, the evidence supports both approaches for different indications—but doesn't support either as universally superior.

So where do you actually stand?

Here's what I want to know: Share one case where you changed your mind—from extraction to non-extraction or vice versa. What did the evidence or long-term follow-up show you?

This isn't a philosophical question. It's a clinical one. The cases that changed your thinking are the ones that matter most.

In a future issue, I'll break down two anonymized cases—one where expansion was clearly right, one where extraction clearly was. But I want to hear from you first.

Reply to this email or comment below. What case changed your thinking?